pmc logo image
Whole-Body Lifetime Occupational Lead Exposure and Risk of Parkinson’s Disease
Steven Coon, Azadeh Stark, Edward Peterson, Aime Gloi, Gene Kortsha, Joel Pounds, David Chettle, and Jay Gorell
Environ Health Perspect. 2006 December; 114(12): 1872–1876. Published online 2006 August 18. doi: 10.1289/ehp.9102.
PMCID: PMC1764163
 Is Cited by the Following Articles in this Archive:
New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals
Luigi Zecca, Chiara Bellei, Patrizia Costi, Alberto Albertini, Enrico Monzani, Luigi Casella, Mario Gallorini, Luigi Bergamaschi, Alberto Moscatelli, Nicholas J. Turro, Melvin Eisner, Pier Raimondo Crippa, Shosuke Ito, Kazumasa Wakamatsu, William D. Bush, Weslyn C. Ward, John D. Simon, and Fabio A. Zucca
Proc Natl Acad Sci U S A. 2008 November 11; 105(45): 17567–17572. Published online 2008 November 6. doi: 10.1073/pnas.0808768105.
PMCID: PMC2582310
α-Synuclein: A therapeutic target for Parkinson’s disease?
Kathleen A. Maguire-Zeiss
Pharmacol Res. Author manuscript; available in PMC 2009 November 1.
PMCID: PMC2630208
Published in final edited form as: Pharmacol Res. 2008; 58(5-6): 271–280. Published online 2008 September 16. doi: 10.1016/j.phrs.2008.09.006.
Manuscript: | Abstract | Full Text | PDF–111K |
Elevated Blood Lead Concentrations in Essential Tremor: A Case–Control Study in Mersin, Turkey
Okan Dogu, Elan D. Louis, Lulufer Tamer, Ozgur Unal, Arda Yilmaz, and Hakan Kaleagasi
Environ Health Perspect. 2007 November; 115(11): 1564–1568. Published online 2007 August 1. doi: 10.1289/ehp.10352.
PMCID: PMC2072853